title: Discontinuation/Interruption of Warfarin Therapy in Patients with Non-Valvular Atrial Fibrillation.
authors.affiliation: The University of Tennessee College of Pharmacy, Memphis, TN, USA.
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.affiliation: The University of Tennessee College of Pharmacy, Memphis, TN, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Qiao
authors.affiliation: The University of Tennessee College of Pharmacy, Memphis, TN, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Spivey
authors.affiliation: University of Tennessee, College of Pharmacy, New York, NY, USA.
authors.forename: X
authors.initials: X
authors.lastname: Liu
authors.affiliation: Bristol-Myers Squibb Company, Princeton, NJ, USA.
authors.forename: H
authors.initials: H
authors.lastname: Phatak
authors.affiliation: Pfizer, Inc., New York, NY, USA.
authors.forename: J
authors.initials: J
authors.lastname: Mardekian
authors.affiliation: Pfizer, Inc., New York, NY, USA.
authors.forename: A B
authors.initials: AB
authors.lastname: Claflin
authors.affiliation: Bristol-Myers Squibb Company, Princeton, NJ, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kachroo
authors.affiliation: Pfizer, Inc., New York, NY, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Abdulsatter
authors.affiliation: The University of Tennessee College of Pharmacy, Memphis, TN, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Parker